Rhinogram vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 35)
Rhinogram logo

Rhinogram

EmergingHealthTech

Patient Communication

Rhinogram is a HIPAA-compliant patient communication platform enabling healthcare providers to text, video chat, and send forms to patients using their existing office phone number.

AI VisibilityBeta
Overall Score
D35
Category Rank
#535 of 596
AI Consensus
87%
Trend
stable
Per Platform
ChatGPT
31
Perplexity
29
Gemini
31

About

Rhinogram provides healthcare practices with a HIPAA-compliant messaging platform that allows clinical and administrative staff to communicate with patients via text message, secure video, and digital forms using the practice's existing landline or VoIP phone number — without sharing personal staff cell numbers. Patients text the office number they already have, and staff manage all conversations through a unified web and mobile inbox that supports multiple simultaneous conversations, message templates, and team assignments.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

35
Overall Score
88
#535
Category Rank
#3
87
AI Consensus
78
stable
Trend
stable
31
ChatGPT
83
29
Perplexity
87
31
Gemini
85
34
Claude
90
34
Grok
92

Key Details

Category
Patient Communication
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Rhinogram
Patient Communication
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.